Assessing Pulmonary Arterial Hypertension using RVSP on 2D Echo

Relationship Between RVSP and SPAP

• RVSP is considered equal to SPAP in the absence of pulmonic valve stenosis or right ventricular outflow tract obstruction 1
• Both measurements are derived from the tricuspid regurgitation (TR) velocity using the modified Bernoulli equation: RVSP = 4v² + RAP, where v is the TR jet velocity and RAP is the estimated right atrial pressure 1
• Multiple studies have shown strong correlations (r = 0.83 to 0.95) between RVSP estimated from TR velocity and invasive hemodynamic measurements from right heart catheterization 1

Diagnostic Approach Using RVSP

• The European Society of Cardiology (ESC) and European Respiratory Society (ERS) recommend using peak tricuspid regurgitation velocity (TRV) rather than the estimated SPAP as the main variable for assigning echocardiographic probability of PH 2
• The ESC/ERS guidelines provide a table for echocardiographic probability of PH based on TRV and other echo signs:

Technical Considerations for Accurate Measurement

• The Doppler beam should be aligned parallel to the TR jet 1
• Multiple transducer positions should be used to record the highest velocity to reduce underestimation 1
• TR jets are analyzable in only 39% to 86% of patients, highlighting the importance of obtaining adequate imaging 1

Limitations and Pitfalls

• Echocardiography may underestimate SPAP by a mean of 11 mmHg, with underestimation of 20 mmHg in up to 31% of patients 1
• In severe tricuspid regurgitation, TRV may be significantly underestimated and cannot be used to exclude PH 2, 1

Confirmation of PAH Diagnosis

• Echocardiography alone is not sufficient to confirm a diagnosis of PAH and initiate treatment 2
• Right heart catheterization is necessary for confirmation of PH in patients with intermediate or high echocardiographic probability of PH before treatment initiation 3

Right Ventricular Systolic Pressure for Pulmonary Hypertension Diagnosis

Diagnostic Thresholds and Significance

• An RVSP value of greater than 40 mm Hg on echocardiography generally warrants further evaluation for pulmonary hypertension in patients with unexplained dyspnea, as recommended by the American College of Cardiology 4, 5
• Additional echocardiographic findings that should trigger further evaluation include right atrial enlargement, right ventricular enlargement, and intraventricular septal flattening, according to the American College of Cardiology 4, 5
• When TR signal is weak, it can be enhanced by intravenous bolus administration of agitated saline contrast or with commercially available encapsulated microbubble contrast agents, as suggested by the American College of Cardiology 4, 5

Clinical Significance and Management Implications

• In submassive pulmonary embolism, an RVSP >40 mm Hg is considered evidence of moderate to severe RV strain and may influence treatment decisions regarding fibrinolysis, as stated by the American Heart Association 6

Common Pitfalls to Avoid

• Relying solely on RVSP without considering other echocardiographic signs of pulmonary hypertension, as warned by the American College of Cardiology 4, 5
• Using exercise-induced increases in RVSP for treatment decisions, as no treatment decisions can be made on the basis of exercise-induced pulmonary hypertension alone, according to the American College of Cardiology 4, 5

RVSP Threshold for Pulmonary Hypertension Workup

Primary Diagnostic Thresholds

• RVSP >30 mmHg is outside the normal range in most healthy individuals and represents an important risk marker, with elevated PA systolic pressure present in 40% of all clinical echocardiograms and carrying a five-year mortality of 25-40% 7
• On right heart catheterization in healthy individuals, average PA systolic pressure is 21 ± 4 mmHg, with upper limit around 30 mmHg, and RVSP >30 mmHg correlates more closely with mean PA pressure ≥20 mmHg, which independently associates with increased mortality 7

Additional Echocardiographic Findings That Trigger Workup

• Decreased tricuspid annular plane excursion (<1.6 cm) should prompt further evaluation 8

Context-Specific Thresholds

• RVSP >45 mmHg is the threshold for considering right heart catheterization to assess pulmonary arterial hypertension before TIPS placement, reflecting the specific hemodynamic challenges of TIPS creation 8

Critical Technical Considerations

• Absence of TR jet does not rule out elevated pulmonary artery pressure, and when TR signal is weak, enhancement with agitated saline or microbubble contrast should be considered 7

Elevated RVSP and Right Heart Strain

Diagnostic Thresholds and Recommendations

• The American College of Cardiology recommends that RVSP >40 mmHg warrants further evaluation in patients with unexplained dyspnea 9
• RVSP >45 mmHg initiates a comprehensive pulmonary hypertension workup at specialized centers, as suggested by research in Circulation Research 10
• The American College of Cardiology suggests that additional echocardiographic findings, such as right atrial enlargement, right ventricular enlargement or dilation, and intraventricular septal flattening, confirm right heart strain 9

Prognostic Implications and Technical Considerations

• Elevated RVSP independently predicts adverse outcomes across multiple cardiovascular conditions, with a hazard ratio of 1.31 for mildly elevated RVSP (40-49 mmHg) and 1.92 for severely elevated RVSP (≥60 mmHg) 9
• The European Heart Journal notes that sleep apnea evaluation is necessary for patients with elevated RVSP 11
• The American College of Cardiology recommends that TR jets be analyzed with agitated saline or microbubble contrast enhancement when the signal is weak, to optimize measurement accuracy 9

Mandatory Next Steps and Specialist Referral

• When RVSP >40 mmHg with unexplained dyspnea, a complete workup, including sleep apnea evaluation, is necessary before right heart catheterization, as suggested by the European Heart Journal 11
• Immediate specialist referral to a pulmonary hypertension center is required for patients with confirmed severe pulmonary hypertension on echocardiography, as management requires expertise in hemodynamic assessment and PAH-specific therapies 9